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Introduction
Dyslipidaemia is classified as a significant risk factor for 
cardiovascular disease (CVD) and is characterised by having 
one or more of the following conditions: serum triglycerides 
(TGs) ≥ 2.26 mmol/l, total serum cholesterol (TC) ≥ 6.20 mmol/l, 
high-density lipoprotein cholesterol (HDL-C) < 1.03 mmol/l and 
low-density lipoprotein cholesterol  (LDL-C) ≥ 3.36 mmol/l if the 
Framingham 10-year risk score is high, or LDL-C ≥ 3.36 mmol/l. 
if the Framingham 10-year risk score is intermediate, or LDL-C 
≥ 4.14 mmol/l if the Framingham 10-year risk score is low.1,2 CVD 
exists largely in developed countries, but in the past decade it has 
also become a problem in the developing world.3 Globally, CVD was 
the main cause of death and disability in 2010.1,4 This is also true 
in South Africa where CVD is responsible for 17% of all deaths. It 
is further estimated that 5.5 million South Africans who are older 
than 30 years are at risk of developing CVD. This may be because 
of raised total serum cholesterol levels (> 5.20 mmol/l),5 as well as 
hypertension (blood pressure of 140/ 90 mmHg),6 which are present 
in 22% and 27% of men and women who are older than 15 years 
respectively.7 Dyslipidaemia, hypertension and obesity [body mass 
index (BMI) ≥ 30 kg/m2]8 are well-known risk factors for CVD.1 Total 
dietary fat, including saturated, polyunsaturated, monounsaturated 
and trans-fatty acids, dietary cholesterol, and saturated fatty acid 
(SFA) intakes (C14, C16 and C18, except in milk and coconut where 
SFA ranges from C4-C18)4 are associated with obesity, undesirable 
serum cholesterol levels and coronary heart disease. However, it is 
important to consider both the quantity and quality of dietary fat. 
Therefore, it is essential that the dietary fat quality guidelines (which 
aim to reduce the incidence and prevalence of chronic lifestyle 
diseases) are followed.9,10 
Although gender and CVD risk factors such as hypertension, 
metabolic syndrome, tobacco usage, overweight and obesity, 
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Objective: Determining the prevalence of dyslipidaemia and examining dietary and other contributing factors, namely hypertension, overweight 
and obesity, as well as abnormal blood lipid levels in women aged 18-90 years. 
Design: Cross-sectional baseline survey study.
Setting: Peri-urban Vaal region. 
Subjects: Seven hundred and twenty-two randomly selected black women in four purposively selected settlements in the Vaal region.
Outcome measures: Measurements included dietary intake (24-hour recall), anthropometric (weight and height), and blood pressure and 
biochemical indices (lipid profile) with venous blood samples. Data analyses included descriptive statistics, t-tests and regression analyses. 
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(BMI) (ß = 0.554, p-value = 0.000), age (ß = 0.419, p-value = 0.000), education (ß = 0.250, p-value = 0.000), total energy intake (ß = 0.105, 
p-value = 0.006) and total fat intake (ß = 0.092, p-value = 0.018) were predictors of dyslipidaemia in these women. 
Conclusion: Dyslipidaemia was prevalent. High triglyceride and low high-density lipoprotein cholesterol levels were the most frequent 
abnormalities. Although positive associations existed between the prevalence of dyslipidaemia and the known risk factors of cardiovascular 
disease, such as ageing, hypertension, obesity and an abnormal lipid profile; BMI, age and education were the main predictors of dyslipidaemia. 
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diabetes and abnormal blood lipid levels have been studied in recent 
years in other countries such as Latin America,11 there is limited 
recent available information on dyslipidaemia, CVD and women in 
South Africa. This study was undertaken in low-income women of 
the Vaal region, a peri-urban area with an unemployment rate of 
47.6%. 46.1% of the households live in poverty.12 The main aim of 
this study was to determine the prevalence of dyslipidaemia and to 
examine dietary and other contributing factors, namely hypertension, 
overweight and obesity and abnormal blood lipid levels in women 
residing in the Vaal region. 
Method
This was a cross-sectional baseline survey study. The study protocol 
was approved by the University of the Witwatersrand Medical Ethics 
Committee for Research on Human Beings (M080931, M070126, 
M080930, M030556). Informed consent was obtained from all the 
participants after the objectives and study procedures had been 
explained to them. The research was conducted according to the 
Declaration of Helsinki’s and the South African Medical Research 
Council’s guidelines for research on human beings. 
A power calculation13 was used to determine the sample size for a 
95% confidence level and 3.75 confidence interval (CI), based on 
the total number of adult women (≥ 20 years) (n = 3 666 111) in 
the Vaal region.14 A sample size of 683 was required for statistical 
representation. Four peri-urban settlements were purposively 
included, based on the criteria of having a low income (< R1 500 per 
household per month) and being predominantly Sotho-speaking.12 
The districts in each of the settlements were randomly selected. 
A residential map was used and the researchers selected every 
fourth household for inclusion in the sample. An extra 39 respondents 
(5.7%) were selected to provide for possible dropouts during the 
data collection period (2008-2011). 
Ten postgraduate students from the Vaal University of Technology 
were recruited and trained as fieldworkers to facilitate completion of 
the questionnaires. A manual was developed to train the fieldworkers 
to ensure a high standard of research. The same fieldworkers worked 
with the recruited respondents from the four settlements to regulate 
the procedures. A registered dietitian and a public health nutritionist 
(registered in the United States of America) took the anthropometric 
measurements. A registered haematologist and qualified nursing 
sisters from a pathology laboratory drew blood, collected the blood 
samples and recorded the blood pressure measurements. Blood 
pressure measurements were taken according to the generic 
measurement principles of the 2011 South African hypertension 
guidelines.6 
Measurements
The age, employment status and monthly household income of the 
respondents were recorded. A 24-hour recall questionnaire was 
administered over a weekend and two weekdays by the trained 
fieldworkers, using food models to obtain quantitative descriptive 
information on dietary intakes. The mean intake over the three 
days was calculated for the various dietary fat intake variables. 
Dietary intake data were analysed by a registered dietitian using the 
Foodfinder® version 3 software programme developed by the Medical 
Research Council and based on the South African food composition 
tables.15 Daily intakes of the dietary fat variables were compared to 
recommended cut-off points for a healthy diet. These cut-off points 
were calculated as a percentage of total energy intake as follows: 
total fat intake 20-35%, SFA ≤ 10%, total polyunsaturated fatty acids 
(PUFA) 6-11%, n-6 PUFA 2.5-9%, n-3 PUFA 0.5-2%, trans-fatty acids 
(TFA) < 1%, and monounsaturated fatty acids (MUFA) the balance.16
Anthropometric measurements included body weight and height 
measured according to standard procedures17 with a calibrated 
Philips® electronic scale [model HF350 (135 kg/100 g) with a 
two-point decimal precision], and a Scales® 2000 stadiometer, 
respectively. All measurements were taken twice and the average of 
the two measurements recorded. BMI was calculated using weight 
(kg) divided by height squared (m2) and categorised according to the 
World Health Organization cut-off points.18 
The participants were asked to fast and were reminded of this by 
short message service the day before the biochemical measurements 
were taken. After a fasting period of approximately 8-10 hours, a 
venous blood sample was drawn before 10h00 with a Vacutainer® 
needle with minimal use of tourniquets. Breakfast was served 
immediately after blood collection. The blood was placed on ice until 
separation within two hours of blood collection. Serum and plasma 
were stored at -800C for two weeks until analysis to prevent changes 
in fatty acid composition as a result of prolonged storage times.19 All 
blood parameters were examined according to standard protocol in 
the biochemical analysis laboratory at the tertiary institution. Total 
serum cholesterol, HDL-C and TG were analysed by means of the 
colorimetric method on a Konelab™® analyser with a coefficient of 
variation (per cent coefficient of variation (CV) between runs of 1.2-
2.8% for all analysed serum variables). In this study, the CV was 
lower than that reported elsewhere.19 The Friedewald formula was 
used to calculate LDL-C.20 
Blood pressure measurements were taken by the registered 
nursing sisters using a Tensoval® digital blood pressure monitor. 
Two measurements were taken and the average of the two 
measurements was used. Blood pressure was defined according to 
the South African hypertension guidelines.6
Statistical analyses
The total group was subdivided into a dyslipidaemic and a 
nondyslipidaemic group. The dyslipidaemic group was classified as 
having one or more of the following conditions:
•	 TG ≥ 2.26 mmol/l 
•	 TC ≥ 6.20 mmol/l
•	 HDL-C < 1.03 mmol/l
•	 LDL-C ≥ 2.59 mmol/l if the Framingham 10-year risk score 
was high, or LDL-C ≥ 3.36 mmol/l if the Framingham 10-year 
risk score was intermediate, or LDL-C ≥ 4.14 mmol/l if the 
Framingham 10-year risk score was low.1,2
All the data were analysed on Stata® version 12.0. Descriptive 
statistics were determined for the dyslipidaemic and nondyslipidaemic 
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groups [means and standard deviations (SDs)], and the two-tailed 
independent t-test, including Levene’s test for equality of means, 
were conducted to determine significant differences (p-value 
< 0.05) between the groups. Concomitantly, two-tailed bivariate 
Pearson correlations were carried out to determine the associations 
between serum lipid concentrations and dietary intake, and BMI 
and hypertension parameters at a 95% confidence level (p-value 
< 0.05). Regression analyses were performed in order to predict the 
risk factors that contributed to the prevalence of dyslipidaemia and 
to determine the variables with the greatest contribution. 
Results
The results show that 34.3% (n = 247) of the women were 
dyslipidaemic. The mean ± SD age of the dyslipidaemic group of 
women was statistically significantly higher (p-value = 0.000) (55.4 
± 0.6 years) than that of the nondyslipidaemic group (41.2 ± 0.5 
years). The same trend was observed for the monthly household 
income (see Table I). 
Significant differences in height (p-value = 0.000), weight (p-value 
= 0.000) and BMI (p-value = 0.001) were observed between the 
two groups. The dyslipidaemic group had the higher means for all 
these parameters. The results show that none of the women was 
underweight and that only 4.9% of the women with dyslipidaemia 
had normal weight compared with 23.9% of the women who 
were nondyslipidaemic (Figure 1). The majority of women in the 
nondyslipidaemic group were overweight (52.6%). However, the 
majority of women in the dyslipidaemic group (86.2%) were obese. 
The hypertension results (Table I) showed that the systolic (p-value 
= 0.014) and diastolic (p-value = 0.029) blood pressure differed 
significantly between the two groups, with higher measurements  in 
the dyslipidaemic group. This is further clarified in Figure 2 which 
shows that despite the fact that the mean ± SD for both systolic and 
diastolic blood pressure was within the normal range for both groups, 
39.3% and 35.6% of the nondyslipidaemic and dyslipidaemic groups 
suffered from hypertension respectively.
The results in Table 1 indicate significant differences (p = 0.000) 
between the mean serum parameters of the two groups. Although 
the mean ± SD values for total serum cholesterol and LDL-C 
indicated no risk of dyslipidaemia in both the groups, the mean 
± SD for TG indicated risk in the women with dyslipidaemia. Of 
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Obesity class 1: body mass index 30-34.99 kg/m2, obesity class 2: body mass index 35-39.99 kg/m2, 
obesity class 3: body mass index ≥ 40 kg/m2 18
Figure 1: Body mass index classification of the dyslipidaemic (n = 247) and 
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Figure 2: Prevalence of hypertension between the dyslipidaemic (n = 247) 
and nondyslipidaemic (n = 475) groups of women 
Table I: Descriptive statistics of socio-economic, biochemical and blood pressure variables that were measured
Variable Unit of measure
(normal range)
Nondyslipidaemic 
(n = 475, 65.7%)
Dyslipidaemic 
(n = 247, 34.3%)
Significant difference 
between groups 
(p-value)*Mean SD Mean SD
Age years 41.20 0.46 55.39 0.61 0.000
Monthly household income R 698.44 338.13 796.89 538.88 0.003
Height m 1.47 0.06 1.51 0.07 0.000
Weight kg 59.21 7.17 77.61 9.76 0.000
Body mass index kg/m2 27.56 3.38 34.11 3.94 0.001
Systolic blood pressure mmHg (< 140)6 127.27 20.94 131.74 24.04 0.014
Diastolic blood pressure mmHg (< 90)6 83.98 14.04 86.12 11.60 0.029
Serum cholesterol mmol/l (< 5.20)5 4.51 0.46 4.30 0.63 0.000
HDL-C mmol/l (> 0.90)5 1.37 0.10 0.96 0.20 0.000
LDL-C mmol/l (≥ 4.14)5 1.22 0.46 2.37 0.66 0.000
Serum triglycerides mmol/l (< 1.70)5 1.22 0.46 2.37 0.66 0.000
* p-value = significant if < 0.05
HDL: high-density lipoprotein, LDL: low-density lipoprotein, R: rands, SD: standard deviation
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± SD HDL-C indicated further risk in the women with dyslipidaemia. 
HDL-C levels of < 1.03 mmol/l were present in 64.3% of the women. 
Two per cent of the women with dyslipidaemia had TC levels 
< 6.20 mmol/l and only 0.4% had LDL-C levels of ≥ 3.36 mmol/l. This 
equates to a dyslipidaemia disease state. Only 0.4% and 1.2% of the 
women presented with two and three of the criteria, respectively. 
None of the women presented with all four of the criteria. The HDL to 
LDL ratio is, however, a better indicator of CVD risk than the individual 
levels of HDL-C and LDL-C. The observed mean ± SD HDL to LDL 
ratio of 2.37 ± 0.66 was significantly higher (p-value = 0.000) in the 
dyslipidaemic group than the 1.22 ± 0.46 in the nondyslipidaemic 
group, but the HDL to LDL ratio was much higher in both groups 
than the recommended > 0.4 ratio. Therefore, this indicates a low 
risk of CVD in this sample of women.21 The total serum cholesterol 
to HDL-C ratio of 3.29 ± 0.34 for the nondyslipidaemic group was 
lower than the recommended 5:1 ratio22 which indicates a low risk 
for CVD. However, the total serum cholesterol to HDL-C ratio of the 
dyslipidaemic group was 5.11 ± 4.5, thus confirming a risk for CVD.22
Despite a statistically significantly (p-value = 0.017) higher intake in 
the dyslipidaemic group, the mean ± SD energy intake of both groups 
was low when compared with the estimated energy requirements 
(see Table II). This was also true for total protein and dietary fibre 
intakes when compared with the estimated average requirements 
(EAR), although these intakes did not differ significantly between 
the groups. In both groups, the mean carbohydrate intakes were 
higher than the EAR. The dyslipidaemic group had a significantly 
higher intake (p-value = 0.007) compared to the nondyslipidaemic 
group. The total fat intake showed low intakes of 20% of total energy 
intake in both groups. According to the guidelines7 for the prevention 
of chronic disease, SFA, PUFA, MUFA, TFA and linoleic acid intakes 
recorded percentages in line with the recommendations for both 
groups, whereas linolenic acid intake percentages (0.2%) were 
much lower than the recommended goal of 0.5-2% in both groups. 
The PUFA intake (5.4%) for the women with dyslipidaemia was 
lower than the recommended 6-11% of total energy intake, whereas 
the nondyslipidaemic women had borderline intake (6.11%). No 
significant differences were observed between the dietary fat intake 
variables between the groups. 
The Pearson correlation analyses revealed that all the serum lipid 
levels significantly (p-value < 0.05) related to hypertension and age. 
A significant (p-value = 0.001) positive association existed between 
the prevalence of dyslipidaemia and age (r = 0.560, p-value = 0.000), 
BMI (r = 0.656, p-value = 0.000), employment (r = 0.260, p-value = 
0.000) and income (r = 0.111, p-value = 0.003) at 99% confidence 
level, as well as total energy intake (r = 0.084, p-value = 0.024) 
at 95% confidence level. A significant negative association was 
observed between the prevalence of dyslipidaemia and education 
level (r = -0.291, p-value = 0.000) at 99% confidence level. 
The linear regression model predicted that BMI (ß = 0.554, p-value 
= 0.000), age (ß = 0.419, p-value = 0.000), education (ß = 0.250, 
p-value = 0.000), total energy intake (ß = 0.105, p-value = 0.006) 
and total fat intake (ß = 0.092, p-value = 0.018) were predictors of 
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energy 
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kJ 4466.20 2074 5078.3 2164.40 0.017 8605 EER**
Total protein g 39.04 24.43 41.95 27.21 0.145 46
Plant protein g 19.01 10.18 19.66 8.59 0.394
Animal protein g 19.85 22.54 21.94 24.73 0.253
Fat g 28.77 26.71 20.0 30.26 29.30 20.0 0.493 20-35% total EI
Cholesterol g 164.04 136.69 151.98 130.22 0.253
SFA g 8.65 9.24 7.3 9.45 11.30 7.0 0.313 < 10% total EI
MUFA 
g 9.83 10.38 10.33 12.20 0.565
Balance [total fat - 
(SFA + TFA + PUFA)]
PUFA g 7.26 9.14 6.1 7.32 7.04 5.4 0.919 6-11% total EI
TFA g 0.43 1.31 0.4 0.37 0.94 0.2 0.567 < 1% total EI
Linoleic acid 
(n-6) C18:2 
g 6.81 8.97 5.7 6.68 6.69 5.0 0.841 2.5-9% total EI
Linolenic acid 
(n-3) C18:3 
g 0.22 0.21 0.19 0.22 0.23 0.16 0.877 0.5-2% total EI
Carbohydrate g 163.77 77.31 179.80 70.58 0.007 100
Dietary fibre g 10.40 6.39 10.84 6.08 0.365 25
* p-value is significant if < 0.050
** Estimated energy requirements were calculated based on mean ± standard deviation age for the total group (46 ± 12 years), mean ± standard deviation height, weight and body mass index of 1.5 ± 0.6 m, 66 
± 12 kg and 30 ± 5 kg/m2 respectively, and moderate activity levels. The estimated energy requirements of 8 605 kJ were calculated as 448 – [7.95 x age (46)] + physical activity level for low active (1.5) x [11.4 x 
weight (66) x height (1.5)] x 4.18 kJ.23
EAR: estimated average requirement, EER: estimated energy requirement, EI: energy intake, FAO: Food and Agriculture Organization of the United Nations, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated 
fatty acids, SD: standard deviation, SFA: saturated fatty acids, TFA: trans-fatty acids, WHO: World Health Organization 
27
Original Research: Prevalence of and contributing factors to dyslipidaemia in low-income women aged 18-90 years
2013;26(1)S Afr J Clin Nutr
dyslipidaemia in these women. No other variables were significant. 
The logistic regression analysis model showed that it was more likely 
that dyslipidaemia would be prevalent with a higher BMI [odds ratio 
(OR) = 1.61, 95% CI: 1.47-1.75, p-value = 0.000], the prevalence of 
hypertension as observed by diastolic blood pressure [OR = 1.05, 
95% CI: 1.02-1.09, p-value = 0.001) and age (OR = 1.23, 95% CI: 
1.19-1.29, p-value = 0.000). The ORs for education, total energy and 
fat intakes were less than one and not significant. 
Discussion
Despite the lack of national data on the prevalence of dyslipidaemia, 
CVD risk factors are prominent in the South African population.24 
Seventeen per cent of all deaths in South Africa in 2000 were 
due to CVD. CVD also contributed to more deaths in women than 
in men.25 Despite abnormally low LDL-C in the nondyslipidaemic 
group and high TG and low levels of HDL-C in the dyslipidaemic 
group, respectively, the means of most of the lipid parameters 
were within the normal range for both the groups, even though 
dyslipidaemia was prevalent in 34.2% of these women. The main 
factors contributing to dyslipidaemia in this study were high TG and 
HDL-C levels. Interestingly, in the group of nondyslipidaemia women, 
the mean ± SD HDL-C value of 1.37 ± 0.10 mmol/l was above the 
cut-off point of 1.03 mmol/l. Although this indicates normal levels, 
this level was not close to the 1.55 mmol/l that is considered to 
be protective against CVD, thus becoming a negative risk factor.1,26 
So, even in the nondyslipidaemia group, the observed HDL-C serum 
levels did not reach the gold standard of 1.55 mmol/l whereby HDL-C 
is no longer a risk factor for CVD. However, the main prognostic lipid 
value is considered to be the total serum cholesterol to HDL-C ratio 
which is known to correlate with the development of acute coronary 
events.1,27 In this study, the total serum cholesterol to HDL-C ratio of 
the dyslipidaemic group confirmed the risk for CVD.22 
Maritz24 indicated that a number of smaller randomly selected studies 
that were undertaken from 1982-1996 in South Africa found that 
25% of black women were hypertensive and hypercholesterolaemic, 
especially older women. This could be the result of a higher 
prevalence of obesity in older women.24 In this study, only 2% of 
the women presented with hypercholesterolaemia which was lower 
than the national prevalence of 32% in black women.28 Research 
also found that the mean total serum cholesterol concentrations 
increased with age, peaking in those from 55-64 years old.11 Total 
serum cholesterol levels were positively significantly associated with 
hypertension and age in this group of women with dyslipidaemia. 
This is consistent with findings in Eastern Poland.29
Hypertension is one of the major and most costly contributors to 
CVD in the South African population. It amounted to an expenditure 
of R4-5 billion in 1991 and constituted 7.5% of the direct total 
healthcare expenditure in the country.6 Hypertension is the most 
commonly found CVD risk factor in the USA and Cuba and strongly 
correlates with CVD in black people.30 In South Africa, the estimated 
hypertension prevalence rate for women was 41.4% in 2008.31 
In this study, the mean systolic and diastolic blood pressure 
was significantly higher in the dyslipidaemic group, although 
hypertension was more prevalent in the nondyslipidaemic women, 
than in those with dyslipidaemia. However, this was not significant. 
The higher prevalence of obesity and the more advanced age of the 
dyslipidaemic group may have contributed to higher blood pressure 
as age and obesity are well-known risk factors of hypertension.32
Although none of the women in this study presented with 
underweight, significantly more nondyslipidaemic women presented 
with normal weight compared to the women with dyslipidaemia. The 
majority of the nondyslipidaemic women were overweight, whereas 
the majority of the women with dyslipidaemia were obese. This high 
rate of obesity is consistent with the 41% obesity prevalence rate 
for women in South Africa.31 The BMI positively and significantly 
correlated with age in this study. The older the participants were, 
the higher their BMI. Ageing is a proven risk factor for CVD in both 
men and women,30 and in Latin America, it was found that with 
every additional five years of age in the elderly, the CVD prevalence 
increased by 11%.33 
The main sources of dietary fat were flesh foods (meat, poultry and 
fish) with a mean ± SD food variety score (FVS) of 3.3 ± 2.6 for a 
seven-day period, followed by fats and oils (mainly sunflower oil) 
with a mean ± SD FVS of 1.5 ± 1.2, and dairy products (milk, cheese 
and sour milk) with a mean ± SD FVS of 1.3 ± 1.5.34 Although the 
total dietary fat intake for both groups was low, the dietary fatty acid 
intakes of the women in this study met the recommended guidelines,16 
except for low PUFA intakes in the women with dyslipidaemia. The 
essential linoleic and alpha-linolenic fatty acids have a positive 
effect on blood lipid concentrations and play an important role in the 
working of the nervous system.35 The main sources of linoleic acid 
in the diet include vegetable oils such as sunflower oil, soybean and 
maize oil, and nuts and seeds. Generally, these are more available 
than the food sources of linolenic acid, including walnuts, linseed 
and rapeseed oil. This was also true in this study in which the diet 
of both the groups almost met the guidelines for linoleic acid, but 
contained a very low intake of linolenic acid, thereby not meeting the 
recommended guideline. In this study, sunflower oil was the main 
contributor to linoleic acid.
BMI, age and education, in this order, were strong predictors 
of dyslipidaemia. Total energy fat intakes showed a weaker 
relationship. The results also confirmed that dyslipidaemia 
correlated with a higher BMI, hypertension and age. Thus, the 
findings of this study are consistent with those of other studies in 
which BMI,36,30 hypertension,30 age30 and education36 were linked 
with dyslipidaemia, and thus CVD risk. Overweight and obesity, a 
higher BMI (≥ 25 kg/m2), and hypertension and age, are well-known 
risk factors for CVD. A higher socio-economic status, as measured 
by years of education and income, has been found to be positively 
and statistically significantly linked with obesity in women in South 
Africa.37 In this study, a positive relationship was shown to exist 
between dyslipidaemia and employment. Therefore, education could 
lead to affluence and the consumption of energy-rich foods, resulting 
in obesity, a major contributing factor to dyslipidaemia and CVD. 
Conclusion and recommendations
High TG and low HDL-C levels were the most frequent abnormalities 
in the women with dyslipidaemia in this study. Although positive 
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associations existed between the prevalence of dyslipidaemia and 
the known risk factors of CVD; BMI, age and education were the 
main predictors of dyslipidaemia. Furthermore, dyslipidaemia was 
more likely to be prevalent with a higher BMI, hypertension and more 
advanced age in this group of women. 
A well-designed, longitudinal study of a statistically representative 
sample should be implemented in the Vaal region to determine the 
presence of the behavioural (diet, smoking and physical activity) 
and metabolic (hypertension, obesity, blood lipid profile, diabetes, 
metabolic syndrome and C-reactive protein) factors that contribute to 
CVD. Furthermore, CVD risk factors should be continually monitored 
and used as tools to develop appropriate actions and to design more 
successful strategies for prevention, early detection and treatment. 
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